PKM and neoplasm: As PKM2 inhibits P53-dependent transactivation of the P21 gene by preventing P53 binding to the P21 promoter, it may lead to increased G1 phase activity, thus providing a growth advantage for tumor cells in the presence of a DNA damage stimulus [25].